If you need more lookups,
subscriptions start at $34 USD/month.
Peter Hudson Location
Melbourne, VIC, AU
Peter Hudson Work
2008 -now CSO (Avipep) and Director (VCB) @ Avipep Pty Ltd and Victorian Cancer Biologics Consortium
2016 -now Co-founder and Snr Scientific Advisor @
2017 -now Co-founder and Board Director @ Isoclide Medical Pty Ltd
2012 -now Founder, Director and CEO @ Diantron Biomed Pty Ltd
2009 -2015 Co-Chair @ HUPO Human Antibody Initiative
2011 -2012 BDM- Business Development @ CRC for Mental Health
2007 -2012 Founder and Director @ AntibOZ Pty Ltd
1995 -2007 Chief Research Scientist (CSIRO); Deputy CEO and Scientific Director (CRC) @ CSIRO and CRC for Diagnostics
1984 -1995 Program Leader and SRS @ CSIRO
1980 -1984 Senior Research Scientist @ Howard Florey Institute (University of Melbourne)
Peter Hudson Education
Australian Academy of Technological Sciences and Engineering (ATSE)
Elected Fellow (FTSE) (Health Care and Healthy Ageing)
2005-2020
Cambridge University (UK)
PhD (Molecular Biology)
1976-1980
Adelaide University
BSc (Hons) (Biochemistry)
1971-1975
Peter Hudson Skills
Protein Design
Protein Therapeutics
Antibody Engineering
Oncology
GMP Manufacture
Molecular Imaging
Molecular Medicine
Clinical Diagnostics
Business Strategy
Entrepreneurship
Research
Microsoft Excel
Peter Hudson Summary
Peter Hudson, based in Melbourne, VIC, AU, is currently a CSO (Avipep) and Director (VCB) at Avipep Pty Ltd and Victorian Cancer Biologics Consortium. Peter Hudson brings experience from previous roles at Cartherics Pty Ltd, Isoclide Medical Pty Ltd, Diantron Biomed Pty Ltd and HUPO Human Antibody Initiative. Peter Hudson holds a 2005 - 2020 Elected Fellow (FTSE) in Health Care and Healthy Ageing @ Australian Academy of Technological Sciences and Engineering (ATSE). With a robust skill set that includes Protein Design, Protein Therapeutics, Antibody Engineering, Oncology, GMP Manufacture and more. Peter Hudson has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Peter Hudson?
Find contact details for 700 million professionals.